Safety and efficacy of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery

European Journal of Anaesthesiology

Volumn 26, Issue 10, 2009, Pages 874-884

  Dahl, Vegard ^a   Pendeville, Philippe E ^b   Hollmann, Markus W ^c   Heier, Tom ^d   Abels, Esther A M ^e   Blobner, Manfred ^f  

^a VESTRE VIKEN HOSPITAL TRUST   (Norway)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d AKER UNIVERSITY HOSPITAL   (Norway)

^e MERCK RESEARCH LABORATORIES   (United States)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cardiovascular diseases; Neuromuscular blockade; Rocuronium; Sugammadex

Indexed keywords

PLACEBO; ROCURONIUM; SUGAMMADEX;

AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEUROMUSCULAR BLOCKING; QT INTERVAL; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE BLIND PROCEDURE;

AGED; ANDROSTANOLS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; ELECTROCARDIOGRAPHY; FEMALE; GAMMA-CYCLODEXTRINS; HEART RATE; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; SINGLE-BLIND METHOD; SURGICAL PROCEDURES, OPERATIVE; TIME FACTORS;

EID: 77951065129     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32832c605b     Document Type: Article

References (24)

1. Saarnivaara L, Klemola UM, Lindgren L, etal. QT interval of the ECG, heart rate and arterial pressure using propofol, methohexital or midazolam for induction of anaesthesia. Acta Anaesthesiol Scand 1990; 34:276-281.
2. Saarnivaara L, Simola M. Effects of four anticholinesterase- anticholinergic combinations and tracheal extubation on QTc interval of the ECG, heart rate and arterial pressure. Acta Anaesthesiol Scand 1998; 42:460-463.
3. Paventi S, Santevecchi A, Ranieri R. Effects of sevoflurane versus propofol on QT interval. Minerva Anestesiol 2001; 67:637-640.
4. Yildirim H, Adanir T, Atay A, et al. The effects of sevoflurane, isoflurane and desflurane on QT interval of the ECG. Eur J Anaesthesiol 2004; 21:566-570.
5. van Vlymen JM, Parlow J L. The effects of reversal of neuromuscular blockade on autonomic control in the perioperative period. Anesth Analg 1997; 84:148-154.
6. Suresh D, Carter JA, Whitehead JP, et al. Cardiovascular changes at antagonism of atracurium: effects of different doses of premixed neostigmine and glycopyrronium in a ratio of 5:1. Anaesthesia 1991; 46:877-880.
7. Goldhill DR, Embree PB, Ali HH, Savarese JJ. Reversal of pancuronium: neuromuscular and cardiovascular effects of a mixture of neostigmine and gylcopyrronium. Anaesthesia 1988; 43:443-446.
8. Van den Broek L, Proost JH, Wierda JM, et al. Neuromuscular and cardiovascular effects of neostigmine and methyl-atropine administered at different degrees of rocuronium-induced neuromuscular block. Eur J Anaesthesiol 1994; 11 :481-487.
9. Caldwell JE. Reversal of residual neuromuscular block with neostigmine at one to four hours after a single intubating dose of vecuronium. Anesth Analg 1995; 80:1168-1174.
10. Bom A, Bradley M, Cameron K, et al. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl 2002; 41 :266-270.
11. Zhang M-Q. Drug-specific cyclodextrins: the future of rapid neuromuscular block reversal. Drugs Future 2003; 28:347 -354.
12. de Boer HD, van Egmond J, van de Pol F, et al. Chemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: reversal ofneuromuscular block in anaesthetized rhesus monkeys. Br J Anaesth 2005; 96:201 -206.
13. de Boer HD, van Egmond J, van de Pol F, et al. Reversal of profound rocuronium neuromuscular blockade by sugammadex in anesthetized rhesus monkeys. Anesthesiology 2006; 104:718-723.
14. Epemolu O, Bom A, Hope F, Mason R. Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969. Anesthesiology 2003; 99:632 -637.
15. Sorgenfrei IF, Norrild K, Larsen PB, et al. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology 2006; 104:667-674.
16. Sparr HJ, Vermeyen KM, Beaufort AM, et al. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics. Anesthesiology 2007; 106:935-943.
17. Gijsenbergh F, Ramael S, Houwing N, van lersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology 2005; 103:695-703.
18. de Boer HD, Driessen JJ, Marcus MA, et al. Reversal ofrocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study. Anesthesiology 2007; 107:239-244.
19. Suy K, Morias K, Cammu G, et al. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anesthesiology 2007; 106:283-288.
20. Puhringer FK, Rex C, Sielenkämper AW, et al. Reversal of profound, high- dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose- finding, safety assessor-blinded, phase II trial. Anesthesiology 2008; 109:188 -197.
21. Cammu G, de Kam PJ, Demeyer I, et al. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers. Br J Anaesth 2008; 100:373-379.
22. de Kam PJ, van Kuijk J, Smeets J, et al. Single IV sugammadex doses up to 32 mg/kg are not associated with QT/QTc prolongation. Anesthesiology 2007; 107:A1580.
23. de Kam PJ, van Kuijk J, Prohn M, et al. Single IV sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium are not associated with QTc prolongation. Eur J Anaesthesiol 2008; 25 (Suppl 44):9A5-19A.
24. Vanacker BF, Vermeyen KM, Struys MM, et al. Reversal of rocuronium- induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane. Anesth Analg 2007; 104:563-568.